Terms: = Breast cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
44 results:
1. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
Su K; Peng Y; Yu H
Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
[TBL] [Abstract] [Full Text] [Related]
2. Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis.
Mandal S; Bandyopadhyay S; Tyagi K; Roy A
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188619. PubMed ID: 34454048
[TBL] [Abstract] [Full Text] [Related]
3. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract] [Full Text] [Related]
4. Proteogenomic and metabolomic characterization of human glioblastoma.
Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L;
Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785
[TBL] [Abstract] [Full Text] [Related]
5. Dark Sweet Cherry (
Layosa MAA; Lage NN; Chew BP; Atienza L; Mertens-Talcott S; Talcott S; Noratto GD
Nutr Cancer; 2021; 73(10):1985-1997. PubMed ID: 32924599
[TBL] [Abstract] [Full Text] [Related]
6. NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.
Watari K; Shibata T; Fujita H; Shinoda A; Murakami Y; Abe H; Kawahara A; Ito H; Akiba J; Yoshida S; Kuwano M; Ono M
Commun Biol; 2020 Mar; 3(1):107. PubMed ID: 32144393
[TBL] [Abstract] [Full Text] [Related]
7. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
Lattanzio R; Iezzi M; Sala G; Tinari N; Falasca M; Alberti S; Buglioni S; Mottolese M; Perracchio L; Natali PG; Piantelli M
BMC Cancer; 2019 Jul; 19(1):747. PubMed ID: 31362705
[TBL] [Abstract] [Full Text] [Related]
8. Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.
Berger AJ; Renner CM; Hale I; Yang X; Ponik SM; Weisman PS; Masters KS; Kreeger PK
Matrix Biol; 2020 Jan; 85-86():80-93. PubMed ID: 31323325
[TBL] [Abstract] [Full Text] [Related]
9. β-Heregulin impairs EGF induced PLC-γ1 signalling in human breast cancer cells.
Rommerswinkel N; Keil S; Adawy A; Hengstler JG; Niggemann B; Zänker KS; Dittmar T
Cell Signal; 2018 Dec; 52():23-34. PubMed ID: 30165102
[TBL] [Abstract] [Full Text] [Related]
10. Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer.
Liu B; Tan J; Wang X; Liu X
Neoplasma; 2018 Mar; 65(3):360-366. PubMed ID: 29788739
[TBL] [Abstract] [Full Text] [Related]
11. Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling.
Liu YR; Cai QY; Gao YG; Luan X; Guan YY; Lu Q; Sun P; Zhao M; Fang C
Phytother Res; 2018 Apr; 32(4):643-650. PubMed ID: 29210118
[TBL] [Abstract] [Full Text] [Related]
12. Expression of phospholipase C isozymes in human breast cancer and their clinical significance.
Cai S; Sun PH; Resaul J; Shi L; Jiang A; Satherley LK; Davies EL; Ruge F; Douglas-Jones A; Jiang WG; Ye L
Oncol Rep; 2017 Mar; 37(3):1707-1715. PubMed ID: 28112359
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands.
Miquel-Cases A; Steuten LM; Rigter LS; van Harten WH
BMC Cancer; 2016 Sep; 16(1):712. PubMed ID: 27595620
[TBL] [Abstract] [Full Text] [Related]
14. A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks breast and Melanoma cancer Cell Invasion.
Raimondi C; Calleja V; Ferro R; Fantin A; Riley AM; Potter BV; Brennan CH; Maffucci T; Larijani B; Falasca M
Sci Rep; 2016 May; 6():26142. PubMed ID: 27199173
[TBL] [Abstract] [Full Text] [Related]
15. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of plcg1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract] [Full Text] [Related]
16. Structure and function of Gab2 and its role in cancer (Review).
Ding CB; Yu WN; Feng JH; Luo JM
Mol Med Rep; 2015 Sep; 12(3):4007-4014. PubMed ID: 26095858
[TBL] [Abstract] [Full Text] [Related]
17. Survival Comparisons for breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.
Onitilo AA; Engel JM; Stankowski RV; Doi SA
Clin Med Res; 2015 Jun; 13(2):65-73. PubMed ID: 25487237
[TBL] [Abstract] [Full Text] [Related]
18. In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.
Sasi W; Ye L; Jiang WG; Sharma AK; Mokbel K
Biomed Res Int; 2014; 2014():648040. PubMed ID: 25162020
[TBL] [Abstract] [Full Text] [Related]
19. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
[TBL] [Abstract] [Full Text] [Related]
20. Recurrent PTPRB and plcg1 mutations in angiosarcoma.
Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
[TBL] [Abstract] [Full Text] [Related]
[Next]
